Wells Fargo’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-1,301,226
| Closed | -$111M | – | 7289 |
|
|
2019
Q4 | $111M | Buy |
1,301,226
+704,224
| +118% | +$47M | 0.03% | 550 |
|
|
2019
Q3 | $29.9M | Buy |
597,002
+349,514
| +141% | +$13.9M | 0.01% | 1187 |
|
|
2019
Q2 | $9.03M | Buy |
247,488
+182,964
| +284% | +$5.97M | ﹤0.01% | 2046 |
|
|
2019
Q1 | $1.8M | Buy |
64,524
+19,735
| +44% | +$465K | ﹤0.01% | 3450 |
|
|
2018
Q4 | $857K | Buy |
44,789
+3,214
| +8% | +$74.8K | ﹤0.01% | 3960 |
|
|
2018
Q3 | $1.24M | Buy |
41,575
+4,592
| +12% | +$173K | ﹤0.01% | 3802 |
|
|
2018
Q2 | $1.36M | Sell |
36,983
-5,763
| -13% | -$187K | ﹤0.01% | 3771 |
|
|
2018
Q1 | $1.41M | Sell |
42,746
-13,593
| -24% | -$425K | ﹤0.01% | 3654 |
|
|
2017
Q4 | $1.54M | Sell |
56,339
-67,045
| -54% | -$2.07M | ﹤0.01% | 3579 |
|
|
2017
Q3 | $4.57M | Buy |
123,384
+18,084
| +17% | +$667K | ﹤0.01% | 2604 |
|
|
2017
Q2 | $4M | Buy |
105,300
+22,380
| +27% | +$997K | ﹤0.01% | 2615 |
|
|
2017
Q1 | $4.05M | Sell |
82,920
-796,916
| -91% | -$36.3M | ﹤0.01% | 2610 |
|
|
2016
Q4 | $29.9M | Sell |
879,836
-2,227
| -0.3% | -$79K | 0.01% | 1111 |
|
|
2016
Q3 | $33.3M | Buy |
882,063
+839,761
| +1,985% | +$31.6M | 0.01% | 971 |
|
|
2016
Q2 | $1.42M | Sell |
42,302
-2,249
| -5% | -$79.3K | ﹤0.01% | 3225 |
|
|
2016
Q1 | $1.42M | Sell |
44,551
-1,035
| -2% | -$33.8K | ﹤0.01% | 3171 |
|
|
2015
Q4 | $1.7M | Buy |
45,586
+1,627
| +4% | +$61.5K | ﹤0.01% | 3097 |
|
|
2015
Q3 | $1.67M | Sell |
43,959
-40,868
| -48% | -$1.43M | ﹤0.01% | 3130 |
|
|
2015
Q2 | $2.43M | Buy |
84,827
+78,324
| +1,204% | +$2.18M | ﹤0.01% | 2952 |
|
|
2015
Q1 | $183K | Buy |
6,503
+781
| +14% | +$21.9K | ﹤0.01% | 4462 |
|
|
2014
Q4 | $158K | Sell |
5,722
-176
| -3% | -$4.36K | ﹤0.01% | 4544 |
|
|
2014
Q3 | $132K | Sell |
5,898
-20,163
| -77% | -$512K | ﹤0.01% | 4536 |
|
|
2014
Q2 | $757K | Sell |
26,061
-83,922
| -76% | -$2.24M | ﹤0.01% | 3693 |
|
|
2014
Q1 | $3.13M | Sell |
109,983
-33,463
| -23% | -$1.11M | ﹤0.01% | 2666 |
|
|
2013
Q4 | $5.54M | Buy |
143,446
+33,197
| +30% | +$1.19M | ﹤0.01% | 2192 |
|
|
2013
Q3 | $3.7M | Sell |
110,249
-23,409
| -18% | -$746K | ﹤0.01% | 2410 |
|
|
2013
Q2 | $4.11M | Buy |
+133,658
| New | +$4.47M | ﹤0.01% | 2262 |
|
Other funds holding MDCO
Wells Fargo's MDCO Position: Q1 2020 in Review
Wells Fargo sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 1,301,226 shares — an estimated $111M sold.
Wells Fargo first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $111M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Wells Fargo reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Wells Fargo sold 1,301,226 Medicines Co shares in Q1 2020, an estimated $111M.
- Wells Fargo first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
- Wells Fargo's Medicines Co position peaked at $111M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Wells Fargo's 13F filing for Q1 2020, filed 14 May 2020.